| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation activator activity | 8.72e-07 | 15 | 103 | 4 | GO:0008494 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.03e-04 | 18 | 103 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | glycine N-acyltransferase activity | 2.61e-04 | 5 | 103 | 2 | GO:0047961 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.98e-04 | 28 | 103 | 3 | GO:0051959 | |
| GeneOntologyBiologicalProcess | female meiosis II | 9.08e-09 | 6 | 104 | 4 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 9.08e-09 | 6 | 104 | 4 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 9.08e-09 | 6 | 104 | 4 | GO:0061983 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 8.37e-06 | 26 | 104 | 4 | GO:0045836 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 1.31e-05 | 29 | 104 | 4 | GO:0045948 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 1.73e-05 | 31 | 104 | 4 | GO:0070935 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 3.54e-05 | 37 | 104 | 4 | GO:0051446 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 4.38e-05 | 77 | 104 | 5 | GO:0048255 | |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 7.75e-05 | 45 | 104 | 4 | GO:0040020 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 7.87e-05 | 87 | 104 | 5 | GO:1902373 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 8.32e-05 | 88 | 104 | 5 | GO:0043489 | |
| GeneOntologyBiologicalProcess | oocyte maturation | 9.21e-05 | 47 | 104 | 4 | GO:0001556 | |
| GeneOntologyBiologicalProcess | female meiotic nuclear division | 1.37e-04 | 52 | 104 | 4 | GO:0007143 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 1.60e-04 | 101 | 104 | 5 | GO:1902369 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | 2.23e-04 | 321 | 104 | 8 | GO:0099003 | |
| GeneOntologyBiologicalProcess | presynaptic active zone assembly | 2.49e-04 | 5 | 104 | 2 | GO:1904071 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 2.93e-04 | 115 | 104 | 5 | GO:1903312 | |
| GeneOntologyBiologicalProcess | olfactory bulb interneuron differentiation | 2.98e-04 | 26 | 104 | 3 | GO:0021889 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB6 FLNB ARHGAP32 CDHR3 SMURF1 APLP2 DICER1 ENAM FOXB1 P2RX7 PTPRZ1 CNTNAP2 ST8SIA2 ROBO1 DLX5 ALCAM | 3.08e-04 | 1194 | 104 | 16 | GO:0000902 |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | FOXO1 DAZ4 ITLN1 SMURF1 HIPK2 MAGI3 S1PR2 DAZ1 STIL CCNY P2RX7 PTPRZ1 RPTOR NFKBIA ROBO1 TAF1 DAZ3 DAZ2 | 3.40e-04 | 1458 | 104 | 18 | GO:0051247 |
| GeneOntologyBiologicalProcess | synaptic vesicle cycle | 3.84e-04 | 264 | 104 | 7 | GO:0099504 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.47e-04 | 25 | 103 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | dendrite | EPHB6 ARHGAP32 PCLO APLP2 DICER1 TH PPP5C PTPRZ1 RPTOR CNTNAP2 ROBO1 LRRC7 ALCAM | 3.02e-04 | 858 | 103 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | EPHB6 ARHGAP32 PCLO APLP2 DICER1 TH PPP5C PTPRZ1 RPTOR CNTNAP2 ROBO1 LRRC7 ALCAM | 3.09e-04 | 860 | 103 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHB6 FLNB ARHGAP32 PCLO SMURF1 APLP2 DICER1 TH PPP5C P2RX7 PTPRZ1 RPTOR CNTNAP2 ROBO1 LRRC7 ALCAM | 3.24e-04 | 1228 | 103 | 16 | GO:0036477 |
| HumanPheno | Oligozoospermia | 2.24e-07 | 59 | 39 | 7 | HP:0000798 | |
| Domain | EYA_dom | 1.73e-04 | 4 | 101 | 2 | IPR006545 | |
| Domain | EYA_fam | 1.73e-04 | 4 | 101 | 2 | IPR028472 | |
| Domain | DHC_N1 | 7.94e-04 | 8 | 101 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 7.94e-04 | 8 | 101 | 2 | IPR013594 | |
| Domain | EF-hand_4 | 1.27e-03 | 10 | 101 | 2 | PF12763 | |
| Domain | CYSTEINE_SWITCH | 1.41e-03 | 41 | 101 | 3 | PS00546 | |
| Domain | EH | 1.54e-03 | 11 | 101 | 2 | PS50031 | |
| Domain | EH | 1.54e-03 | 11 | 101 | 2 | SM00027 | |
| Domain | EH_dom | 1.54e-03 | 11 | 101 | 2 | IPR000261 | |
| Domain | Pept_M10_metallopeptidase | 1.62e-03 | 43 | 101 | 3 | IPR001818 | |
| Domain | WW | 2.09e-03 | 47 | 101 | 3 | PF00397 | |
| Domain | WW | 2.23e-03 | 48 | 101 | 3 | SM00456 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.53e-03 | 14 | 101 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.53e-03 | 14 | 101 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.53e-03 | 14 | 101 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.53e-03 | 14 | 101 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 2.53e-03 | 14 | 101 | 2 | IPR011704 | |
| Domain | MT | 2.53e-03 | 14 | 101 | 2 | PF12777 | |
| Domain | AAA_8 | 2.53e-03 | 14 | 101 | 2 | PF12780 | |
| Domain | AAA_5 | 2.53e-03 | 14 | 101 | 2 | PF07728 | |
| Domain | WW_DOMAIN_1 | 2.65e-03 | 51 | 101 | 3 | PS01159 | |
| Domain | WW_DOMAIN_2 | 2.65e-03 | 51 | 101 | 3 | PS50020 | |
| Domain | WW_dom | 2.80e-03 | 52 | 101 | 3 | IPR001202 | |
| Domain | DHC_fam | 2.90e-03 | 15 | 101 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 2.90e-03 | 15 | 101 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.90e-03 | 15 | 101 | 2 | IPR004273 | |
| Domain | Carb_anhydrase | 3.73e-03 | 17 | 101 | 2 | PF00194 | |
| Domain | Carb_anhydrase | 3.73e-03 | 17 | 101 | 2 | SM01057 | |
| Domain | - | 3.73e-03 | 17 | 101 | 2 | 3.10.200.10 | |
| Domain | ALPHA_CA_2 | 3.73e-03 | 17 | 101 | 2 | PS51144 | |
| Domain | Carbonic_anhydrase_a | 3.73e-03 | 17 | 101 | 2 | IPR001148 | |
| Domain | Pept_M10A_stromelysin-type | 4.19e-03 | 18 | 101 | 2 | IPR016293 | |
| Domain | PG_binding_1 | 5.16e-03 | 20 | 101 | 2 | PF01471 | |
| Domain | Peptidoglycan-bd-like | 5.16e-03 | 20 | 101 | 2 | IPR002477 | |
| Pubmed | The sperm-associated antigen 6 interactome and its role in spermatogenesis. | DAZ4 DAZ1 BABAM2 GDA NFKBIA KIAA1328 ZFR DAZ3 DAZ2 WDR17 REV1 | 2.82e-11 | 199 | 106 | 11 | 31146259 |
| Pubmed | 5.95e-11 | 10 | 106 | 5 | 31234534 | ||
| Pubmed | 8.15e-11 | 4 | 106 | 4 | 7670487 | ||
| Pubmed | 8.15e-11 | 4 | 106 | 4 | 11694340 | ||
| Pubmed | 8.15e-11 | 4 | 106 | 4 | 9321470 | ||
| Pubmed | 8.15e-11 | 4 | 106 | 4 | 19223287 | ||
| Pubmed | Impact of partial DAZ1/2 deletion and partial DAZ3/4 deletion on male infertility. | 8.15e-11 | 4 | 106 | 4 | 26232607 | |
| Pubmed | [Microdeletion of chromosome Y in male infertility: role of the DAZ gene]. | 8.15e-11 | 4 | 106 | 4 | 11688365 | |
| Pubmed | 8.15e-11 | 4 | 106 | 4 | 12752250 | ||
| Pubmed | A novel approach for the analysis of DAZ gene copy number in severely idiopathic infertile men. | 8.15e-11 | 4 | 106 | 4 | 11883873 | |
| Pubmed | Partial DAZ deletions in a family with five infertile brothers. | 8.15e-11 | 4 | 106 | 4 | 12801575 | |
| Pubmed | Analysis of the DAZ gene family in cryptorchidism and idiopathic male infertility. | 8.15e-11 | 4 | 106 | 4 | 15066457 | |
| Pubmed | Male infertility caused by a de novo partial deletion of the DAZ cluster on the Y chromosome. | 8.15e-11 | 4 | 106 | 4 | 11095434 | |
| Pubmed | Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. | 8.15e-11 | 4 | 106 | 4 | 10936047 | |
| Pubmed | [Study on DAZ gene copy deletion in severe oligozoospermia sperm donor for ICSI]. | 8.15e-11 | 4 | 106 | 4 | 16963411 | |
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 23579190 | ||
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 20008336 | ||
| Pubmed | Isolation of a mouse homolog of the human DAZ (Deleted in Azoospermia) gene. | 4.07e-10 | 5 | 106 | 4 | 8679003 | |
| Pubmed | AZFc partial deletions in Chilean men with severe spermatogenic failure. | 4.07e-10 | 5 | 106 | 4 | 17416365 | |
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 22293198 | ||
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 11089564 | ||
| Pubmed | A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype. | 4.07e-10 | 5 | 106 | 4 | 10393944 | |
| Pubmed | The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. | 4.07e-10 | 5 | 106 | 4 | 8968756 | |
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 8968755 | ||
| Pubmed | DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions. | 4.07e-10 | 5 | 106 | 4 | 30380414 | |
| Pubmed | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis. | 4.07e-10 | 5 | 106 | 4 | 26411291 | |
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 34985827 | ||
| Pubmed | Expression profiling of the developing testis in wild-type and Dazl knockout mice. | 4.07e-10 | 5 | 106 | 4 | 14648873 | |
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 8896558 | ||
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 9700189 | ||
| Pubmed | Kinked β-strands mediate high-affinity recognition of mRNA targets by the germ-cell regulator DAZL. | 4.07e-10 | 5 | 106 | 4 | 22021443 | |
| Pubmed | The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. | 4.07e-10 | 5 | 106 | 4 | 9288969 | |
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 23456578 | ||
| Pubmed | In vivo and in vitro analysis of homodimerisation activity of the mouse Dazl1 protein. | 4.07e-10 | 5 | 106 | 4 | 10903443 | |
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 9143498 | ||
| Pubmed | Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells. | 4.07e-10 | 5 | 106 | 4 | 22699882 | |
| Pubmed | A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. | 4.07e-10 | 5 | 106 | 4 | 8845845 | |
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 11058556 | ||
| Pubmed | Dazl promotes germ cell differentiation from embryonic stem cells. | 4.07e-10 | 5 | 106 | 4 | 19783541 | |
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 17761180 | ||
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 19468308 | ||
| Pubmed | Partial rescue of the Dazl knockout mouse by the human DAZL gene. | 4.07e-10 | 5 | 106 | 4 | 12200456 | |
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 11514340 | ||
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 23298641 | ||
| Pubmed | DAZL is essential for stress granule formation implicated in germ cell survival upon heat stress. | 4.07e-10 | 5 | 106 | 4 | 22223682 | |
| Pubmed | Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. | 4.07e-10 | 5 | 106 | 4 | 23223451 | |
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 11804965 | ||
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 21270429 | ||
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 8661148 | ||
| Pubmed | DAZL binds to the transcripts of several Tssk genes in germ cells. | 1.22e-09 | 6 | 106 | 4 | 18452650 | |
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 24086306 | ||
| Pubmed | DAZL binds to 3'UTR of Tex19.1 mRNAs and regulates Tex19.1 expression. | 1.22e-09 | 6 | 106 | 4 | 19247806 | |
| Pubmed | DAZL is a master translational regulator of murine spermatogenesis. | 1.22e-09 | 6 | 106 | 4 | 31355046 | |
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 20157580 | ||
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 28496037 | ||
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 1.22e-09 | 6 | 106 | 4 | 26077710 | |
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 17526644 | ||
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 1638086 | ||
| Pubmed | Spermatogenesis in testes of Dazl null mice after transplantation of wild-type germ cells. | 1.22e-09 | 6 | 106 | 4 | 14611632 | |
| Pubmed | Expression profiles of the DAZ gene family in human testis with and without spermatogenic failure. | 1.22e-09 | 6 | 106 | 4 | 15066460 | |
| Pubmed | The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. | 1.22e-09 | 6 | 106 | 4 | 23417416 | |
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 32170089 | ||
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 16278232 | ||
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 17219433 | ||
| Pubmed | The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. | 1.22e-09 | 6 | 106 | 4 | 16001084 | |
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 32962040 | ||
| Pubmed | Genetic mapping of a male germ cell-expressed gene Tpx-2 to mouse chromosome 17. | 1.22e-09 | 6 | 106 | 4 | 1869307 | |
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 11390979 | ||
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 27632217 | ||
| Pubmed | 2.83e-09 | 7 | 106 | 4 | 15081113 | ||
| Pubmed | 2.83e-09 | 7 | 106 | 4 | 22699423 | ||
| Pubmed | 2.83e-09 | 7 | 106 | 4 | 11604102 | ||
| Pubmed | Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. | 2.83e-09 | 7 | 106 | 4 | 16946704 | |
| Pubmed | 2.83e-09 | 7 | 106 | 4 | 10857750 | ||
| Pubmed | 2.83e-09 | 7 | 106 | 4 | 11410654 | ||
| Pubmed | The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. | 2.83e-09 | 7 | 106 | 4 | 9588208 | |
| Pubmed | DAZL and CPEB1 regulate mRNA translation synergistically during oocyte maturation. | 2.83e-09 | 7 | 106 | 4 | 26826184 | |
| Pubmed | Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. | 5.65e-09 | 8 | 106 | 4 | 23204224 | |
| Pubmed | 5.65e-09 | 8 | 106 | 4 | 29883445 | ||
| Pubmed | 5.65e-09 | 8 | 106 | 4 | 10823932 | ||
| Pubmed | 5.65e-09 | 8 | 106 | 4 | 11869379 | ||
| Pubmed | 5.65e-09 | 8 | 106 | 4 | 10951504 | ||
| Pubmed | Mouse dead end1 acts with Nanos2 and Nanos3 to regulate testicular teratoma incidence. | 5.65e-09 | 8 | 106 | 4 | 32339196 | |
| Pubmed | 5.65e-09 | 8 | 106 | 4 | 33749946 | ||
| Pubmed | 5.65e-09 | 8 | 106 | 4 | 22621333 | ||
| Pubmed | 5.65e-09 | 8 | 106 | 4 | 32686646 | ||
| Pubmed | Dazl deficiency leads to embryonic arrest of germ cell development in XY C57BL/6 mice. | 1.01e-08 | 9 | 106 | 4 | 16310179 | |
| Pubmed | A Gene Regulatory Program for Meiotic Prophase in the Fetal Ovary. | 1.01e-08 | 9 | 106 | 4 | 26378784 | |
| Pubmed | Embryoid bodies from mouse stem cells express oxytocin receptor, Oct-4 and DAZL. | 1.01e-08 | 9 | 106 | 4 | 19695304 | |
| Pubmed | 1.01e-08 | 9 | 106 | 4 | 28235998 | ||
| Pubmed | 1.01e-08 | 9 | 106 | 4 | 20159962 | ||
| Pubmed | Tesmin transcription is regulated differently during male and female meiosis. | 1.69e-08 | 10 | 106 | 4 | 14648882 | |
| Pubmed | MAX controls meiotic entry in sexually undifferentiated germ cells. | 1.69e-08 | 10 | 106 | 4 | 38433229 | |
| Pubmed | 1.69e-08 | 10 | 106 | 4 | 23810942 | ||
| Pubmed | 1.69e-08 | 10 | 106 | 4 | 12837688 | ||
| Pubmed | 1.69e-08 | 10 | 106 | 4 | 10601091 | ||
| Pubmed | 1.69e-08 | 10 | 106 | 4 | 9922113 | ||
| Pubmed | NANOS2 suppresses the cell cycle by repressing mTORC1 activators in embryonic male germ cells. | 2.65e-08 | 11 | 106 | 4 | 34401671 | |
| Pubmed | High frequency of DAZ1/DAZ2 gene deletions in patients with severe oligozoospermia. | 2.75e-08 | 3 | 106 | 3 | 11870237 | |
| Pubmed | EPS15 FLNB STAM2 ARHGAP32 COBLL1 TM9SF3 MAGI3 FCHO2 FAM83B EPS15L1 ROBO1 LRRC7 LTV1 PLCH1 | 3.48e-08 | 708 | 106 | 14 | 39231216 | |
| Interaction | KCNA3 interactions | EPS15 FLNB STAM2 ARHGAP32 COBLL1 TM9SF3 MAGI3 FCHO2 FAM83B EPS15L1 RPTOR ROBO1 LRRC7 LTV1 PLCH1 DNAH5 | 7.51e-06 | 871 | 102 | 16 | int:KCNA3 |
| Interaction | SIX5 interactions | 1.33e-05 | 29 | 102 | 4 | int:SIX5 | |
| Cytoband | Yq11.223 | 6.69e-05 | 93 | 106 | 4 | Yq11.223 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr18q12 | 1.03e-04 | 104 | 106 | 4 | chr18q12 | |
| Cytoband | 18q12.2 | 7.02e-04 | 17 | 106 | 2 | 18q12.2 | |
| Cytoband | 18q12.1 | 1.66e-03 | 26 | 106 | 2 | 18q12.1 | |
| Cytoband | 1p32 | 1.79e-03 | 27 | 106 | 2 | 1p32 | |
| GeneFamily | Dyneins, axonemal | 3.48e-05 | 17 | 69 | 3 | 536 | |
| GeneFamily | EYA transcriptional coactivator and phosphatases | 8.57e-05 | 4 | 69 | 2 | 1044 | |
| Coexpression | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN | 6.91e-10 | 12 | 104 | 5 | MM781 | |
| Coexpression | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN | 1.13e-07 | 12 | 104 | 4 | MM742 | |
| Coexpression | WAGSCHAL_EHMT2_TARGETS_UP | 1.95e-06 | 23 | 104 | 4 | MM1293 | |
| Coexpression | MATZUK_SPERMATOGONIA | 6.78e-06 | 31 | 104 | 4 | MM765 | |
| Coexpression | GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_DN | 8.66e-06 | 183 | 104 | 7 | M7627 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 8.76e-06 | 33 | 104 | 4 | MM701 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL | 1.19e-05 | 268 | 104 | 8 | M45696 | |
| Coexpression | GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP | 1.49e-05 | 199 | 104 | 7 | M8396 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | FLNB TM9SF3 KCTD4 SMURF1 ZDHHC14 HIPK2 SORBS1 TPGS2 EYA3 ZNF519 PCDH17 ALMS1 PTPRZ1 ZFR ALCAM | 2.96e-05 | 1102 | 104 | 15 | M2369 |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-07 | 169 | 106 | 7 | 8c96e1baa38ec5e777e627ab9dbce025e771f2c0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells-Airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-07 | 169 | 106 | 7 | 86041be5d3aeab5b9269f7912791b944f325a1b4 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-07 | 169 | 106 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.42e-07 | 188 | 106 | 7 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 3.54e-07 | 189 | 106 | 7 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | (0)_Normal/No_Treatment-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 3.67e-07 | 190 | 106 | 7 | ff083168d609957d00888f31b3488d6d56c902b4 | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.94e-07 | 192 | 106 | 7 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.85e-07 | 198 | 106 | 7 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.85e-07 | 198 | 106 | 7 | 6ba5e5970109a04ed968bac7ff099ae250c579dc | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.01e-07 | 199 | 106 | 7 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.01e-07 | 199 | 106 | 7 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.01e-07 | 199 | 106 | 7 | 667b8b47a5b388506e3177b46747267fad8024f6 | |
| ToppCell | Control-Epithelial_airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.18e-06 | 158 | 106 | 6 | 35aee1c3b92169e73569331022833cb44ab7e7e8 | |
| ToppCell | Control-Epithelial_airway-Club_cells-Airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.10e-06 | 168 | 106 | 6 | ce87981f4da2779de952c2e5d2bbcdabb265e705 | |
| ToppCell | Control-Epithelial_airway-Club_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.10e-06 | 168 | 106 | 6 | e85bc5398eb36b2b0773a8a7082e3ba740452165 | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.21e-06 | 169 | 106 | 6 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.92e-06 | 182 | 106 | 6 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Fibcd1_(ventral_GP_(vGP))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.23e-06 | 48 | 106 | 4 | 89449efbb229f36d415ca80e5519308997ec106d | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Fibcd1_(ventral_GP_(vGP))--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.23e-06 | 48 | 106 | 4 | 63d5d3bbfa9446676d3a53409bc59192abaeabd7 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Fibcd1_(ventral_GP_(vGP))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.23e-06 | 48 | 106 | 4 | 6cedbfa330eb1c18d7254cb26ddd5f5d3e6d7359 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 5.41e-06 | 185 | 106 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.57e-06 | 186 | 106 | 6 | f73cb91e74a806858650ae97f543fc779ba4cff8 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.57e-06 | 186 | 106 | 6 | 8694ca16c9780729f4fba67ba20e35745f1eb4e9 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.57e-06 | 186 | 106 | 6 | 74eb69a52090f9e2426a47e03a1c478ee0cfec18 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.93e-06 | 188 | 106 | 6 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.93e-06 | 188 | 106 | 6 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.30e-06 | 190 | 106 | 6 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 6.69e-06 | 192 | 106 | 6 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 6.69e-06 | 192 | 106 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.89e-06 | 193 | 106 | 6 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | 15|World / Age, Tissue, Lineage and Cell class | 6.89e-06 | 193 | 106 | 6 | a8ad0de955494d6f5929dc44ba46627d06d95453 | |
| ToppCell | Control-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 6.89e-06 | 193 | 106 | 6 | 2a6d531abd34df20941cf3dac4fdfb1621a1bde6 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.09e-06 | 194 | 106 | 6 | 2172d951896265243d14996eacce5aab5e14e26e | |
| ToppCell | Control-Myeloid-MoAM5,_CCL3L1|Myeloid / Condition, Lineage and Cell class | 7.09e-06 | 194 | 106 | 6 | 96400477d130b2403ed81c229e4e4182cc2cdc14 | |
| ToppCell | Control-Myeloid-MoAM5,_CCL3L1|Control / Condition, Lineage and Cell class | 7.09e-06 | 194 | 106 | 6 | a1dd264822de83a0ffaf89ca4707c6a76809359e | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.09e-06 | 194 | 106 | 6 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | CTRL-Myeloid-Monocyte_Macrophage|CTRL / Disease state, Lineage and Cell class | 7.09e-06 | 194 | 106 | 6 | 927480f56cccd3940b689f3c40ee132fe3e63745 | |
| ToppCell | (0)_Normal/No_Treatment-(1)_VE-Cad+_vascular_cells|(0)_Normal/No_Treatment / Stress and Cell class | 7.30e-06 | 195 | 106 | 6 | e8ab3122f81cb22920becd6611cbd9f00db19d50 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.30e-06 | 195 | 106 | 6 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.52e-06 | 196 | 106 | 6 | 70384c1da9baed843f414cfd1403ddd586a2db07 | |
| ToppCell | MS-IIF-Lymphocyte-B-B_memory|IIF / Disease, condition lineage and cell class | 7.97e-06 | 198 | 106 | 6 | ae6f1d3ca7d7aa6f6f45b6b51aa8a967cadde017 | |
| ToppCell | PCW_13-14-Epithelial|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.97e-06 | 198 | 106 | 6 | 48eb6f69a464a34ab32e8d425a22b9d45ec20428 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.97e-06 | 198 | 106 | 6 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.97e-06 | 198 | 106 | 6 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.97e-06 | 198 | 106 | 6 | 641e7be258303bb9782d19fcf8693f317581d3b8 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.20e-06 | 199 | 106 | 6 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Airway-Club|LPS_only / Treatment groups by lineage, cell group, cell type | 8.20e-06 | 199 | 106 | 6 | 165ac94b2d56072ad43358b5127d77555221e2d8 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Airway-Club|Control_saline / Treatment groups by lineage, cell group, cell type | 8.20e-06 | 199 | 106 | 6 | 5cc8b553a58669a30eb10845beb23983dcdf5a6a | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.20e-06 | 199 | 106 | 6 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Airway-Club|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.20e-06 | 199 | 106 | 6 | 8649c2380285a668782d75eb076ce548eed0911d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.20e-06 | 199 | 106 | 6 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.20e-06 | 199 | 106 | 6 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.44e-06 | 200 | 106 | 6 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.44e-06 | 200 | 106 | 6 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.44e-06 | 200 | 106 | 6 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 | |
| ToppCell | Mild/Remission-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.79e-05 | 148 | 106 | 5 | dd5e1bc02824e743e1c030a303e32f27a359a8ca | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.17e-05 | 152 | 106 | 5 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.59e-05 | 156 | 106 | 5 | 0f2147abcf31a26ee5b2f4d8c5d72232612a33f0 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.59e-05 | 156 | 106 | 5 | cb87f12443fdc5538b856f765fcbac9406044e10 | |
| ToppCell | LPS-IL1RA-Epithelial_airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.17e-05 | 161 | 106 | 5 | 472c354f5ee148b37a5dfb795e83348ecb1643f1 | |
| ToppCell | LPS-antiTNF-Epithelial_airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.83e-05 | 166 | 106 | 5 | eb942ed68677e55c46cb039046f45686d4062d7c | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.83e-05 | 166 | 106 | 5 | 1df4bdf7c773cbfa6c93d7a901f9cd3f3fe07a3d | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.83e-05 | 166 | 106 | 5 | 9628522e7af8f8edca733588a364ab2454ac5ca5 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 5.41e-05 | 170 | 106 | 5 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 5.41e-05 | 170 | 106 | 5 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | ICU-SEP-Lymphocyte-B-B_intermediate|ICU-SEP / Disease, Lineage and Cell Type | 5.56e-05 | 171 | 106 | 5 | 2e44bf6f3d90193e7cadcac48bb852bd632a81bc | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.56e-05 | 171 | 106 | 5 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.56e-05 | 171 | 106 | 5 | 5e93c76ee60f9d0590ebb140812653a5e1369417 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.87e-05 | 173 | 106 | 5 | 3aa1d28d4814798a772808ed29e1dbbdf92abd03 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.87e-05 | 173 | 106 | 5 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.87e-05 | 173 | 106 | 5 | e8afef5ae68983eb8d6515b43952636a47e9d3d4 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-05 | 173 | 106 | 5 | 66f37c1437705734b20601656fa4aa1d92ca30be | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-05 | 173 | 106 | 5 | 649b08a409095592cccf31883be69c754411280d | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 6.20e-05 | 175 | 106 | 5 | 7de1023161233b64f11e130881c742f4cf2bff65 | |
| ToppCell | pdx-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.37e-05 | 176 | 106 | 5 | 1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.37e-05 | 176 | 106 | 5 | ad05dd934f4ac2e656b3455de091f4c8772de6c8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.37e-05 | 176 | 106 | 5 | 05ec715439f2eb1696f5d8855da0dd1dd70effd0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.55e-05 | 177 | 106 | 5 | 382f0d6bbff01e84b0c7840e74ac865864e6da89 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-05 | 178 | 106 | 5 | 58857bb8c13e0e1c6d9f5c1258f00fff62063d68 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.72e-05 | 178 | 106 | 5 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-05 | 178 | 106 | 5 | 8b7df6ab8709d9ab9dff97677cc4561aec2745bc | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-05 | 178 | 106 | 5 | b0baf5667e3301898b3e45e974b8a8530af6a338 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-05 | 180 | 106 | 5 | f8bdfd7bf7b3d52c659a29d8f5f80858e79da83e | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.09e-05 | 180 | 106 | 5 | 8e96f8646c002768b272359af485dc0ab57e0ccd | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 7.27e-05 | 181 | 106 | 5 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.47e-05 | 182 | 106 | 5 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.47e-05 | 182 | 106 | 5 | fa16e194f04250149c82e86551270b244cbc8af4 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B|Lung / Manually curated celltypes from each tissue | 7.47e-05 | 182 | 106 | 5 | 310f94437d197eaaaf6e30e68063b33e94befe77 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 7.66e-05 | 183 | 106 | 5 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.66e-05 | 183 | 106 | 5 | 27a57cd8ea924420e182f3d72f5b29b00dea8fa0 | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-05 | 183 | 106 | 5 | 3991830726d05cf19606d540de04093985b7bdeb | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-05 | 183 | 106 | 5 | cc844f54c7564bf432b179ca63bc7c4b9b8cfdd9 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.66e-05 | 183 | 106 | 5 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 7.66e-05 | 183 | 106 | 5 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 184 | 106 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.86e-05 | 184 | 106 | 5 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 184 | 106 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 184 | 106 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.86e-05 | 184 | 106 | 5 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.86e-05 | 184 | 106 | 5 | e343dd7777a29048e3f12a939f7f782b8b7b4fea | |
| Drug | boron trichloride | 5.88e-09 | 6 | 103 | 4 | CID000025135 | |
| Drug | BW755C | 2.17e-07 | 93 | 103 | 7 | CID000047795 | |
| Drug | Vistar | 5.79e-07 | 36 | 103 | 5 | CID000040896 | |
| Drug | desmethylazelastine | 6.89e-07 | 16 | 103 | 4 | CID000162558 | |
| Drug | dazmegrel | 1.45e-06 | 19 | 103 | 4 | CID000053555 | |
| Drug | YM 026 | 1.45e-06 | 19 | 103 | 4 | CID000004443 | |
| Drug | AZFd | 3.27e-06 | 23 | 103 | 4 | CID000196489 | |
| Drug | dansylaziridine | 3.27e-06 | 23 | 103 | 4 | CID000104008 | |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; MCF7; HT_HG-U133A | 3.33e-06 | 198 | 103 | 8 | 5289_UP | |
| Drug | d-gluconhydroximo-1,5-lactam | 1.13e-05 | 31 | 103 | 4 | CID000003479 | |
| Drug | CK2 inhibitor 2 | 2.08e-05 | 36 | 103 | 4 | CID005326976 | |
| Drug | 3-bromo-7-nitroindazole | 2.08e-05 | 36 | 103 | 4 | CID000001649 | |
| Drug | Procainamide hydrochloride [614-39-1]; Down 200; 14.8uM; PC3; HT_HG-U133A | 2.91e-05 | 194 | 103 | 7 | 4602_DN | |
| Drug | Iocetamic acid [16034-77-8]; Up 200; 6.6uM; PC3; HT_HG-U133A | 3.10e-05 | 196 | 103 | 7 | 4600_UP | |
| Drug | 5-aza-2'-deoxycytidine | EPHB6 EYA4 DAZ4 INSIG1 DAZ1 SORBS1 DICER1 NFKBIA ROBO1 LRRC7 DAZ3 DAZ2 | 3.16e-05 | 638 | 103 | 12 | CID000016886 |
| Drug | Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; HL60; HG-U133A | 3.21e-05 | 197 | 103 | 7 | 1578_DN | |
| Drug | Picrotoxinin [17617-45-7]; Up 200; 13.6uM; HL60; HT_HG-U133A | 3.21e-05 | 197 | 103 | 7 | 2161_UP | |
| Drug | Cyclopenthiazide [742-20-1]; Down 200; 10.6uM; HL60; HT_HG-U133A | 3.53e-05 | 200 | 103 | 7 | 2905_DN | |
| Drug | molybdenum disulfide | 4.26e-05 | 43 | 103 | 4 | CID000014823 | |
| Drug | 2-chlorodideoxyadenosine | 4.26e-05 | 43 | 103 | 4 | CID000072194 | |
| Drug | propham | 4.67e-05 | 44 | 103 | 4 | CID000024685 | |
| Disease | Male sterility due to Y-chromosome deletions | 7.93e-09 | 8 | 98 | 4 | C2931163 | |
| Disease | Partial chromosome Y deletion | 7.93e-09 | 8 | 98 | 4 | C1507149 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 1.93e-05 | 16 | 98 | 3 | C1839071 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 1.93e-05 | 16 | 98 | 3 | cv:C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 1.93e-05 | 16 | 98 | 3 | 415000 | |
| Disease | eye disease (implicated_via_orthology) | 1.62e-04 | 6 | 98 | 2 | DOID:5614 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | 1.94e-04 | 477 | 98 | 8 | C0005586 | |
| Disease | branchiootorenal syndrome (implicated_via_orthology) | 2.27e-04 | 7 | 98 | 2 | DOID:14702 (implicated_via_orthology) | |
| Disease | smoking status measurement, high density lipoprotein cholesterol measurement | 2.27e-04 | 7 | 98 | 2 | EFO_0004612, EFO_0006527 | |
| Disease | Ectrodactyly | 2.27e-04 | 7 | 98 | 2 | C0265554 | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 2.66e-04 | 93 | 98 | 4 | DOID:3525 (biomarker_via_orthology) | |
| Disease | carbohydrate measurement | 4.86e-04 | 46 | 98 | 3 | EFO_0004998 | |
| Disease | Crohn's disease | 6.83e-04 | 441 | 98 | 7 | EFO_0000384 | |
| Disease | corneal resistance factor | 7.79e-04 | 451 | 98 | 7 | EFO_0010067 | |
| Disease | Bardet-Biedl Syndrome | 8.32e-04 | 13 | 98 | 2 | C0752166 | |
| Disease | Major Depressive Disorder | 1.33e-03 | 243 | 98 | 5 | C1269683 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 1.44e-03 | 17 | 98 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | susceptibility to chronic sinus infection measurement | 1.52e-03 | 68 | 98 | 3 | EFO_0008419 | |
| Disease | Unipolar Depression | 1.75e-03 | 259 | 98 | 5 | C0041696 | |
| Disease | body mass index, high density lipoprotein cholesterol measurement | 1.80e-03 | 19 | 98 | 2 | EFO_0004340, EFO_0004612 | |
| Disease | triglyceride measurement, body mass index | 1.80e-03 | 19 | 98 | 2 | EFO_0004340, EFO_0004530 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 1.89e-03 | 157 | 98 | 4 | DOID:14330 (implicated_via_orthology) | |
| Disease | urinary microalbumin measurement | 2.00e-03 | 20 | 98 | 2 | EFO_0010967 | |
| Disease | triglyceride measurement, body fat percentage | 2.20e-03 | 21 | 98 | 2 | EFO_0004530, EFO_0007800 | |
| Disease | C-reactive protein measurement | ORC3 OLFML2B CDHR3 COBLL1 BABAM2 PCDH17 RANBP17 PPP5C P2RX7 ZMIZ2 DNAH17 | 2.21e-03 | 1206 | 98 | 11 | EFO_0004458 |
| Disease | otitis media (implicated_via_orthology) | 2.42e-03 | 22 | 98 | 2 | DOID:10754 (implicated_via_orthology) | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-b measurement | 3.12e-03 | 25 | 98 | 2 | EFO_0021970 | |
| Disease | body fat percentage, high density lipoprotein cholesterol measurement | 3.12e-03 | 25 | 98 | 2 | EFO_0004612, EFO_0007800 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QIPTGNSLYESYYKQ | 11 | Q9UBC2 | |
| KNLLAPGYTETYYNS | 76 | Q9UKQ2 | |
| NPAASYYNVDVLKYQ | 646 | Q0JRZ9 | |
| YSQYREKPSIFYQQS | 1286 | Q8TCU4 | |
| NNQLPVYYTYKTVVN | 26 | Q4L235 | |
| QFNINVPSSVYAKYY | 261 | Q8ND76 | |
| VQPTTSYSIQNLYSY | 1211 | Q9UPY3 | |
| YYEPLLKNNSTAYST | 536 | Q8TAM1 | |
| QVTTGYQLPVYNYQA | 321 | Q13117 | |
| VTTGYQLPVYNYQAF | 346 | Q13117 | |
| FQVTTGYQLPVYNYQ | 416 | Q13117 | |
| QVTTGYQLPVYNYQA | 441 | Q13117 | |
| VTTGYQLPVYNYQAF | 466 | Q13117 | |
| QVTTGYQLPVYNYQA | 321 | Q9NR90 | |
| VQVTTGYQLPVYNYQ | 416 | Q9NR90 | |
| VEVKNYPENTYYSNF | 166 | P23280 | |
| PTSASYGKALNPYQY | 61 | P56178 | |
| STASYLKNYPLYRQD | 696 | Q53SF7 | |
| YLEKFYQLPSNQYQS | 36 | P22894 | |
| SDLLQYRKLSQSYYP | 876 | Q9H2T7 | |
| IYTYVSVNPTNGAIY | 521 | O14917 | |
| DYPTYTILGQNQYQA | 196 | Q99504 | |
| YYLLANTKFTSQPGY | 381 | Q7Z304 | |
| QNHGYENPTYKYLEQ | 746 | Q06481 | |
| AQKTASYYSPYGQRE | 216 | Q8WWA0 | |
| VYTGYPLSPAKVNQY | 1181 | Q9H2X6 | |
| TYSNLYNHPQLIKYQ | 356 | Q96GA3 | |
| PQYGTYYVDHLNQKT | 351 | Q5TCQ9 | |
| AIQKNYSPYYNTIDD | 196 | P35527 | |
| GTYKVYNIPLENYAS | 956 | Q96NW7 | |
| HYTNTYQIYSKDPQN | 71 | Q6IB77 | |
| SPLLNYNTGVYRSYQ | 976 | Q5T0W9 | |
| YNTGVYRSYQPNENK | 981 | Q5T0W9 | |
| YKQLPQDLGTAYYLT | 256 | Q96DC8 | |
| PELYNGNYSTTQKTF | 156 | P05160 | |
| NYDYSHTVKYTPTQQ | 901 | O75369 | |
| KIRQIYQYNYDPSGT | 3311 | Q9Y6V0 | |
| SYALYQVQTGSLPVY | 6 | Q538Z0 | |
| VAPVDYLSQYGYLQK | 26 | Q99542 | |
| VYRADTQTYQPYNKD | 71 | P84090 | |
| QFLVYNGVYQYTSPD | 226 | O15503 | |
| GYLYITQKQTLTKYP | 41 | Q8WVF5 | |
| YNEALKLYSPSSQQY | 971 | O95163 | |
| ADVNRVTYQGYSPYQ | 241 | P25963 | |
| LPNSTDKYYIYNGSL | 221 | P23471 | |
| PLYQYKPYQSSQARS | 1616 | A7KAX9 | |
| YYSGSTNYNPSLKSR | 71 | P01825 | |
| YLSIARPQTYYQTKQ | 211 | Q86T90 | |
| RNTYSDQKPPYSYIS | 6 | Q99853 | |
| KTTNVSLYPGYNFRY | 281 | Q99572 | |
| YIVTSLLGYRKYQPN | 1051 | Q6YHK3 | |
| AVYTAYSQTGQPYSL | 176 | O95677 | |
| SPSPNYQKYTYGQSS | 416 | Q12778 | |
| QVTTGYQLPVYNYQA | 651 | Q9NQZ3 | |
| VTTGYQLPVYNYQAF | 676 | Q9NQZ3 | |
| SGQLYSQAQKNYPYS | 336 | Q9NXR7 | |
| QIQYSYEYLGNTPRL | 1806 | Q9UFH2 | |
| YKNNVYVYILTSPEN | 441 | Q6ZTQ4 | |
| DTSKYPKGYFVQNTY | 191 | P08236 | |
| TPNFKYAQLNVSYSG | 166 | A0A0U1RQE8 | |
| VADPYYIQASTYVQK | 216 | P28300 | |
| PNTITYGYYNKAVLE | 846 | O75064 | |
| NLDYNYYSVPIQIKD | 636 | Q08554 | |
| PSYKNYTSVYDKNNL | 256 | Q9Y2T3 | |
| VGYNPEKYSVTQLVY | 651 | Q9UHC6 | |
| YEGEQYTSNQPKEYL | 686 | Q9NRM1 | |
| QLSSGNPVYEKYYRQ | 11 | P42566 | |
| NPVYEKYYRQVDTGN | 16 | P42566 | |
| QVTTGYQLPVYNYQA | 486 | Q86SG3 | |
| VTTGYQLPVYNYQAF | 511 | Q86SG3 | |
| YVTPKNYLDFINTYS | 3016 | Q8IVF4 | |
| SEYLNPNKVQEHYNY | 6 | O95136 | |
| INQTEESPYINGRYY | 456 | Q13740 | |
| DNYLQYIQSLPAYDS | 4296 | Q8TE73 | |
| TALNNPYYYLKNEAL | 601 | Q9UBD5 | |
| IYVYLQPSDSYAQDQ | 256 | Q8NGZ4 | |
| TQKNTASSGNYYFIP | 171 | Q6ZN16 | |
| TNYKPVANHQYNIEY | 151 | P13984 | |
| QYLQQKGFSPALQYY | 441 | Q9NUP7 | |
| YAYYSNIATKTPLDQ | 631 | Q68CR1 | |
| APQRLQYYDSYNSKV | 61 | A0A075B6R0 | |
| VSPGKYYTYASTRNN | 81 | A0A075B6R0 | |
| YTTAQQKYFSNYSPV | 541 | Q96NR3 | |
| NLSNDEYYYPKQQGL | 566 | P21675 | |
| YSQAIELNPSNAIYY | 51 | P53041 | |
| QLQQYSSPGLGVKYY | 631 | O15197 | |
| YLTTYNQGYFENIPK | 341 | Q7Z5V6 | |
| DQNQNPVKYHYYDSL | 321 | Q92186 | |
| QYQSIVPALYEYTSQ | 1176 | Q8IZU2 | |
| YQNGYILSPLSYKLT | 296 | Q8WUT9 | |
| NEYSYTTQIDYNPKD | 716 | Q68BL8 | |
| SYLYNSKEPGVQAYI | 146 | Q9UBF8 | |
| VFNKNYTQYIPLSIY | 166 | Q8N122 | |
| LNPYYGLFQYSTDNI | 456 | Q9HCE7 | |
| TIYYNLLYGNISASP | 561 | O75027 | |
| PYQDKLVGYITNYSR | 16 | Q8WUX2 | |
| ITQNYINYGTTKSYG | 531 | Q9P2U8 | |
| NLNISQVQGTYKYGY | 221 | Q15468 | |
| VSLAVYSYYNQGILP | 41 | Q8TB69 | |
| YQDAITLNPKYSLAY | 371 | Q86TZ1 | |
| YLNSVIYTNQPTAQY | 356 | Q8N443 | |
| YIPYQLYTKQSSVQK | 126 | Q9UBZ9 | |
| QDLFSYQALYSYIPQ | 1231 | Q9BX66 | |
| YSYKYKDQPQQTFNI | 461 | Q9NY15 | |
| YNKLVNEAPVYSVYS | 361 | O75886 | |
| TGKPYYYNNQSKESR | 146 | Q6NWY9 | |
| SQYIQGYKILYRPSG | 701 | Q9Y6N7 | |
| IYNQKQLTRIYPSAY | 646 | Q4KWH8 | |
| KENYNPYSYGNIFTN | 296 | Q8IZN3 | |
| KRTYSEVYPGQQYLQ | 266 | Q8NF64 | |
| QYAFTSYGISPQAKQ | 206 | Q68CL5 | |
| NTVGPYHNRQETYKY | 46 | Q9HD45 | |
| PAVAYDSKQYYQQPT | 151 | Q96KR1 | |
| YLYVYKNVSQLSPDG | 646 | Q9Y2L5 | |
| PTSTEEQYKINIYYQ | 956 | Q5SVZ6 | |
| RKAQSVYSSYLQIYP | 501 | Q08AF3 | |
| QPYQDQTYQSVYFVS | 451 | P07101 |